RE-BVS – Piemonte Repository

Sfoglia per AUTORE
NANNI M
Collezione AOU Città della Salute di Torino

Items : 4

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. in Haematologica / Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116.

2023
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Foà R; Nanni M; Del Giudice I; Guarini A; Fazi P; Vignetti M; Piciocchi A; Cuneo A; Neri A; De Novi LA; De Propris MS; Pietrasanta D; Mattiello V; Visentin A; Vitale C; Albano F; Molinari MC; Liberati AM; Giordano A; Gottardi D; Galieni P; Patrizi VB; Tani M; Arcari A; Musuraca G; Deodato M; Massaia M; Rigolin GM; Scarfò L; et alii...

Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study. in Cancers / Cancers (Basel). 2021 Dec 31;14(1):207. doi: 10.3390/cancers14010207.

2021
AOU Alessandria
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Piciocchi A; Cuneo A; Foà R; Rigolin GM; Fazi P; Neri A; Guarini A; Raponi S; Nanni M; De Propris MS; Della Starza I; Ibatici A; Murru R; Ruocco V; Del Giudice I; Varettoni M; Molinari A; Gentile M; Chiarenza A; Laurenti L; Gottardi D; Zinzani PL; Gozzetti A; Tani M; Musuraca G; Orsucci L; Re F; Di Renzo N; Liberati AM; et alii...

High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2). in Haematologica / Haematologica. 2020 Nov 1;105(11):2671-2674. doi: 10.3324/haematol.2019.235705.

2020
AOU Alessandria
AOU Città della Salute di Torino

Della Starza I; Del Giudice I; Cuneo A; Albano F; Neri A; Vignetti M; Piciocchi A; Nanni M; Musolino C; Del Poeta G; Battistini R; Gozzetti A; Pietrasanta D; Reda G; Tedeschi A; Liberati AM; Re F; Angelucci E; Zaja F; Coscia M; Ilariucci F; Soddu S; Molica S; Mauro FR; De Propris MS; Raponi S; Guarini AR; Foà R;

Effectiveness of a brief manualized intervention, Managing Cancer and Living Meaningfully (CALM), adapted to the Italian cancer care setting: Study protocol for a single-blinded randomized controlled trial. in Contemporary clinical trials communications / Contemp Clin Trials Commun. 2020 Oct 10;20:100661. doi: 10.1016/j.conctc.2020.100661. eCollection 20

2020
AOU Città della Salute di Torino

Sabato S; Leombruni P; Zerbinati L; Miniotti M; Bovero A; Murri MB; De Padova S; Bertelli T; Malfitano C; Hales S; Rodin G; Caruso R; Nanni MG; Grassi L;